Roivant Sciences Ltd

22 ott 2026, 20:07 UTC

Roivant Sciences Ltd shares rose during Thursday's session, showing unusual strength with an early spike before retracing, and remain significantly above their 20-day moving average.

21 ott 2026, 23:41 UTC

Roivant Sciences Ltd is advancing in after-market trading, having gained since Wednesday's close and currently positioned above its 20-day moving average.

20 ott 2026, 20:08 UTC

Roivant Sciences Ltd is trading modestly higher, closing slightly above Monday's close but remains 1.31% below its 20-day moving average.

19 ott 2026, 20:51 UTC

Roivant Sciences Ltd is trading lower in after-market hours, having pulled back from a brief high earlier in the session and remaining below its 20-day moving average.

16 ott 2026, 22:26 UTC

Roivant Sciences Ltd shares traded higher in after-market hours, maintaining a slight increase from earlier lows amid broader market concerns over inflationary pressures.

15 ott 2026, 19:51 UTC

Roivant Sciences Ltd is advancing alongside a broader rise in the Biotechnology sector, as CEO Matt Gline expressed frustration over investor agreements at the #STATSummit.

13 ott 2026, 20:01 UTC

Roivant Sciences Ltd shares fell, diverging from recent gains, amid broader market declines, although Citi placed the company on its positive catalyst watch.

12 ott 2026, 23:56 UTC

Roivant Sciences Ltd is trading higher in after-hours action, having previously peaked before a slight retracement, but remains below its 20-day moving average.

9 ott 2026, 19:51 UTC

Roivant Sciences Ltd shares are advancing today, supported by unusually high trading volume, breaking a recent trend of higher daily closes since Thursday.

8 ott 2026, 20:07 UTC

Roivant Sciences Ltd shares declined amid negative sentiment from parent company Immunovant following caution from H.C. Wainwright regarding IMVT-1402's mid-stage study.

7 ott 2026, 22:02 UTC

Roivant Sciences Ltd saw a notable rise in after-market trading, gaining ground since Wednesday's close, despite being below its 20-day moving average.

6 ott 2026, 20:07 UTC

Roivant Sciences Ltd shares fell sharply, reaching a midday low and remaining significantly below their 20-day moving average.

5 ott 2026, 23:45 UTC

Roivant Sciences Ltd is trading slightly higher in after-market hours, following earlier gains, despite remaining below its 20-day moving average.

2 ott 2026, 22:02 UTC

Roivant Sciences Ltd is experiencing a significant decline in after-market trading, reaching its lowest point of the day amid unusual volatility.

1 ott 2026, 20:31 UTC

Roivant Sciences Ltd is trading higher in after-market hours, continuing its advance since Thursday's close, despite earlier pulling back from a session high.

30 set 2026, 21:10 UTC

Roivant Sciences Ltd traded lower in after-market hours, closing at its lowest point of the day and significantly below its 20-day moving average.

29 set 2026, 22:35 UTC

Roivant Sciences Ltd saw a slight decline in after-market trading, remaining near the lower end of its one-month range and below its 20-day moving average.

28 set 2026, 22:01 UTC

Roivant Sciences Ltd is rising in after-market trading, advancing from a low point shortly after the market closed, though still below its 20-day moving average.

25 set 2026, 21:20 UTC

Roivant Sciences Ltd saw a notable increase in after-market trading, recovering from a low point and advancing higher since Friday's close.

24 set 2026, 23:55 UTC

Roivant Sciences Ltd is seeing a slight uptick in after-market hours, despite remaining roughly flat since Thursday's close and below its 20-day moving average.

23 set 2026, 20:02 UTC

Roivant Sciences Ltd shares fell sharply after Immunovant discontinued IMVT-1402 development for cutaneous lupus erythematosus due to a failed proof-of-concept study.

22 set 2026, 23:55 UTC

Roivant Sciences Ltd is higher in after-market trading following positive Phase 2 trial results for mosliciguat, showing significant improvements in pulmonary hypertension patients.

21 set 2026, 23:51 UTC

Roivant Sciences Ltd is advancing in after-market trading, currently 3.88% above its 20-day moving average and near the upper end of its one-month range.

18 set 2026, 23:10 UTC

Roivant Sciences Ltd is trading modestly higher in after-market hours, supported by broader market gains and resilient U.S. retail sales data.

17 set 2026, 23:21 UTC

Roivant Sciences Ltd is seeing notable gains in after-market trading, continuing an upward trend after finishing higher for three consecutive sessions.

16 set 2026, 23:11 UTC

Roivant Sciences Ltd shares rise in after-market trading following Stifel's initiation of coverage with a Buy rating and a price target of $51.00.

15 set 2026, 23:03 UTC

Roivant Sciences Ltd is higher in after-market trading, aligning with the broader market's upward movement. The asset remains above its 20-day moving average.

14 set 2026, 20:13 UTC

Shares of Roivant Sciences are lower in after-market hours, reflecting a notable decline since Monday's close, despite remaining above the 20-day moving average.

11 set 2026, 20:13 UTC

Roivant Sciences Ltd. shares are lower in after-market trading, amid broader market concerns over potential Federal Reserve interest rate hikes following recent inflation data.

10 set 2026, 23:31 UTC

Roivant Sciences Ltd shares are lower in after-market trading, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.